BMS Scales AI Across Drug Discovery

Company Bristol Myers Squibb Event Type Technology Infrastructure Expansion Modality AI-Enabled Drug Discovery Platform Platform NVIDIA DGX SuperPOD (Vera Rubin NVL72) Indication Oncology, Hematology, Cardiovascular Disease, Immunology, Neuroscience Summary Bristol Myers Squibb is expanding its NVIDIA collaboration with a second DGX SuperPOD built on eight…